| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.11. | Range Impact reports Q3 results | 2 | Seeking Alpha | ||
| 14.11. | Range Impact, Inc.: Range Impact Reports 3Q 2025 Financial Results | 100 | GlobeNewswire (Europe) | Cleveland, Ohio, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public impact investing company dedicated to acquiring, reclaiming and repurposing... ► Artikel lesen | |
| 14.11. | RANGE IMPACT, INC. - 8-K, Current Report | - | SEC Filings | ||
| 14.11. | RANGE IMPACT, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 24.09. | Range Impact raises $550,000 | 1 | Seeking Alpha | ||
| 24.09. | Range Impact, Inc.: Range Impact Announces $550,000 Capital Raise | 1 | GlobeNewswire (USA) | ||
| 24.09. | RANGE IMPACT, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.08. | Range Impact GAAP EPS of -$0.01, revenue of $1.39M | 3 | Seeking Alpha | ||
| RANGE IMPACT Aktie jetzt für 0€ handeln | |||||
| 14.08. | RANGE IMPACT, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.08. | Range Impact, Inc.: Range Impact Reports 2Q 2025 Financial Results | 142 | GlobeNewswire (Europe) | Cleveland, Ohio, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public impact investing company dedicated to acquiring, reclaiming and repurposing... ► Artikel lesen | |
| 14.08. | RANGE IMPACT, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.07. | RANGE IMPACT, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 03.07. | Range Impact, Inc.: Range Impact Announces Expansion of Investment in its Fola Mine Complex with Acquisition of Two Mining Permits and Two Coal Leases | 181 | GlobeNewswire (Europe) | CLEVELAND, OHIO, July 02, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming and repurposing distressed... ► Artikel lesen | |
| 04.06. | RANGE IMPACT, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.05. | Range Impact, Inc.: Range Impact Reports 1Q 2025 Financial Results | 118 | GlobeNewswire (Europe) | Cleveland, Ohio, May 15, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public impact investing company dedicated to acquiring, reclaiming and repurposing... ► Artikel lesen | |
| 02.04. | Range Impact, Inc.: Range Impact Announces Major Land Acquisition in West Virginia | 138 | GlobeNewswire (Europe) | CLEVELAND, OHIO, April 02, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming and repurposing distressed... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 40,555 | +3,76 % | Novo Nordisk: Knallharter Preiskampf | Die Börsenwoche steht unter keinem guten Stern. Der DAX rutscht heute weiter ab. Zuletzt mehrten sich Befürchtungen, dass der große Hype um Aktien aus dem Segement Künstliche Intelligenz (KI) zu einer... ► Artikel lesen | |
| AURORA CANNABIS | 3,870 | +1,84 % | Aurora Cannabis Inc.: Aurora Cannabis Announces Fiscal 2026 Second Quarter Results | Expands YoY Global Medical Cannabis Net Revenue 1 by 15% to Record $70.5 million
Increases International Medical Cannabis Net Revenue 1 by 22% to... ► Artikel lesen | |
| CANOPY GROWTH | 1,024 | +3,12 % | Canopy Growth Corp (2): Canopy Growth adds new Spectrum softgels in Australia | ||
| TILRAY BRANDS | 0,847 | +1,00 % | Neue Regeln für medizinisches Cannabis: Warum Neural Therapeutics in Deutschland mit Hanf.com profitieren könnte | ||
| VERTEX PHARMACEUTICALS | 370,80 | +0,77 % | VERTEX PHARMACEUTICALS INC stürzt ab - Alarmstufe Rot! | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT Global CEO Saxon resigns | ||
| CRONOS GROUP | 2,160 | +1,79 % | Stocks in Play: Cronos Group Inc. | ||
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures to Resume Trading on the Canadian Securities Exchange | Vancouver, British Columbia--(Newsfile Corp. - November 10, 2025) - Digicann Ventures Inc. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the... ► Artikel lesen | |
| EYEPOINT PHARMACEUTICALS | 12,625 | +1,04 % | EyePoint Pharmaceuticals, Inc.: EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU in Wet Age-Related Macular Degeneration | - No changes in protocol recommended for LUGANO and LUCIA clinical trials - - Masked safety data continues to show no safety signals, consistent with previous clinical trials for DURAVYU - - On track... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,420 | +4,41 % | Organigram Global Inc: Organigram appoints Yamanaka as CEO | ||
| GREEN THUMB INDUSTRIES | 4,972 | -1,35 % | Green Thumb Industries Reports Third Quarter 2025 Results | CHICAGO and VANCOUVER, British Columbia, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| MYDECINE INNOVATIONS GROUP | 0,150 | 0,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON 22.10.2025 | The following instruments on XETRA do have their first trading 22.10.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 22.10.2025
Aktien
1 KYG8827C1006 Malibu Life Holdings... ► Artikel lesen | |
| ASTRIA THERAPEUTICS | 10,700 | 0,00 % | BioCryst Pharmaceuticals, Inc.: BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile | - Deal to add navenibart, a late-stage and long-acting plasma kallikrein inhibitor, in Phase 3 clinical development, to BioCryst's HAE portfolio - - Solidifies double digit growth trajectory for HAE... ► Artikel lesen | |
| SANTHERA PHARMACEUTICALS | 12,960 | +1,25 % | Santhera Pharmaceuticals: Phoenix aus der Asche | ||
| TONIX PHARMACEUTICALS | 12,400 | 0,00 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces FDA IND Clearance for Phase 2 Study of TNX-102 SL for the Treatment of Major Depressive Disorder | Tonix plans to initiate potential pivotal Phase 2 HORIZON study of TNX-102 SL in adults with major depressive disorder in mid-2026 More than 21 million US adults experience a major depressive episode... ► Artikel lesen |